[news] February 4th report of Beijing (Kang Meilai) a major breakthrough, our company and the Medical University Of Anhui cooperative research and development project "preclinical" capsule Phellinus linteus medicine for treating malignant tumor of national innovation. The National Center for natural products research group of the project chief scientist Dr. Lining and the University of Mississippi School of medicine to carry out international cooperation, for the first time in the international research found that the monomer composition and fingerprint of Phellinus linteus kill cancer cells, liver cancer, gastric cancer research showed that PI for cervical cancer, breast cancer, tumor inhibition rate reached 78%--86%.

The United States University of Mississippi phellinuslinteus Kang mirae jointly made a major breakthrough

"The project before the clinical study of Phellinus linteus national new drug for treating malignant tumor capsule was in 2016 by the Anhui provincial government approved by the relevant departments for the" project of major scientific and technological projects in Anhui Province, and city and county levels of financial support. In recent years, due to the explosive growth of cancer patients, the Ministry of science and technology and Anhui province has been listed as a major research and development of innovative anti-cancer drugs.

The United States University of Mississippi phellinuslinteus Kang mirae jointly made a major breakthrough

Currently, Dr. Lining is the University of Mississippi as a visiting scholar, and the University's top team of scientists research topic of Phellinus igniarius. The project is at the international advanced level, bringing hope to the rehabilitation of cancer patients.